MK-8353 Catalog No.:M19981-C Smiles: C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C

Smiles: C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C

CAS Number: 861038-72-4

treatment with 50 mg/kg of Erythromycin dihyrate shortens mean survival time in tumorbearing mice by 4-5 days when it compares to controls

Bromo-PEG2-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs

5-dihydro-1H-pyrrol-1-yl)ethoxy]ethoxy}propanoic acid

MK-8353 Catalog No.:M19981-C Smiles: C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1CMK 8353 (SCH900353) is a potent, selective and orally available ERK1 2 inhibitor, with IC50s of 23. 0 nM and 8. 8 nM, respectively; MK 8353 has antitumor activity. Product information CAS Number: 1184173 73 6 Molecular Weight: 691. 84 Formula: C37H41N9O3S Chemical Name: (3S) 1 (2 {4 [4 (1 methyl 1H 1,2,4 triazol 3 yl)phenyl] 1,2,3,6 tetrahydropyridin 1 yl} 2 oxoethyl) 3 (methylsulfanyl) N {3 [6 (propan 2 yloxy)pyridin 3 yl] 1H indazol 5 yl}pyrrolidine